Agonist-induced internalization of G protein-coupled receptors (GPCRs) is a well characterized phenomenon believed to contribute to receptor desensitization. The 5-hydroxytryptamine (5-HT) 2C subtype of serotonin receptor is a GPCR that we have shown to internalize upon agonist incubation. In this study, we have examined the effects of 5-HT 2C on the internalization of a C-terminal green fluorescent protein (GFP)-tagged 5-HT 2C receptor (VSV isoform) expressed in transiently transfected human embryonic kidney cells. We detected internalization with an automated, cell-based fluorescence-imaging system (Arrayscan) and monitored function with intracellular Ca 2ϩ measurements (flourometric imaging plate reader). The 5-HT 2C -GFP construct exhibited appropriate pharmacology, and we observed that although all three agonists resulted in similar magnitudes of dose-dependent internalization, the partial agonists resulted in ϳ50% less internalization, and the inverse agonists and neutral antagonists failed to induce internalization. These results were confirmed by confocal microscopy. They demonstrate that the 5-HT 2C receptor is internalized by incubation with agonists and partial agonists but not with inverse agonists or neutral antagonists.
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Agonist induced internalization of G protein-coupled receptors (GPCRs) is a well characterized phenomenon believed to contribute to receptor desensitization. Upon agonist binding, GPCRs undergo conformational changes that result in activation of heterotrimeric G protein subunits, which activate or inhibit downstream targets such as nucleotide cyclases, phospholipases, and kinases. Subsequent to receptor-effector coupling, second messenger-dependent protein kinases and G protein receptor kinases phosphorylate the receptor, which promotes recruitment of ␤-arrestins, uncoupling of heterotrimeric G proteins, and internalization in clathrin-coated vesicles (for review, see Ferguson, 2001 ). Although such internalization is typically associated with agonist induction, antagonists have been shown to induce internalization of several GPCRs, including the 5-hydroxytryptamine (5-HT) 2A receptor (Willins et al., 1998) , the cholecystokinin receptor (Roettger et al., 1997) , the vasopressin V 2 receptor (Pfeiffer et al., 1998) , and the A 1 adenosine receptor (Navarro et al., 1999) , indicating that the ligand dependence of GPCR internalization is a receptor-specific property.
Although agonist-and antagonist-induced internalization has been studied for the 5-HT 2A serotonin receptor, it has not been examined for the closely related 5-HT 2C receptor subtype. The 5-HT 2C receptor functions through the same mechanism as the other members of the 5-HT 2 family, activating phospholipase C, promoting the hydrolysis of membrane phospholipids, leading to increases in the intracellular levels of inositol phosphates and intracellular calcium (for review, see Boess and Martin, 1994) . Both the 5-HT 2A and 5-HT 2C receptor subtypes have received considerable attention in pharmaceutical drug discovery. In the case of the 5-HT 2A receptor subtype, it has been recognized that drugs that are used to treat both schizophrenia and depression, in addition to hallucinogenic agents, display affinity for this target (Canton et al., 1990) . The 5-HT 2C receptor has been implicated in a variety of conditions, including obesity, anxiety, depression, obsessive compulsive disorder, schizophrenia, migraine, nociception, and erectile dysfunction (Fozard and Gray, 1989; Kennett and Curzon, 1991; Sanders-Bush and Breeding, 1991; Gibson et al., 1994; Bos et al., 1997; Millan et al., 1997; Sasaki et al., 2003) . Consequently, a number of pharmacological agents targeting both activation and antagonism of the 5-HT 2C receptor have been described previously (Bos et al., 1997; Kennett et al., 1996 Kennett et al., , 1997 Bishop and Nilsson, 2003) .
To gain insight into the regulation of the 5-HT 2C receptor subtype by ligands with both positive and negative intrinsic activity, we examined the ligand dependence of 5-HT 2C receptor internalization by evaluating agonist and antagonist effects on internalization and desensitization. The 5-HT 2C receptor undergoes RNA editing to generate multiple isoforms, and the predominant human VSV isoform (Niswender et al., 2001 ) was chosen for study because this isoform will be a significant determinant of drug action in the human central nervous system. We tagged the C terminus of the 5-HT 2C receptor (VSV isoform) with GFP and confirmed appropriate functional pharmacology by intracellular calcium measurements using a fluorometric imaging plate reader (FLIPR; Molecular Devices, Sunnyvale, CA). Internalization was then monitored by measuring the formation of clusters of tagged receptors trafficked to endocytic recycling compartments (ERCs) using an automated, cell-based fluorescence imaging system (Arrayscan II; Cellomics, Pittsburgh, PA). Our results demonstrate that 5-HT 2C receptor agonists and partial agonists promote receptor internalization, whereas both inverse agonists and neutral antagonists do not. In addition, agonist intrinsic activity was similar for promoting internalization compared with a more conventional assay of functional receptor coupling, calcium mobilization.
Materials and Methods
Cloning of 5-HT 2C -GFP. 5-HT 2C -GFP was cloned by polymerase chain reaction amplification. The segment between a native, unique AvaI site and the C terminus of the gene was amplified by polymerase chain reaction using primers to remove the stop codon and add a ClaI site. The N-terminal portion of the receptor was obtained by cutting template with NotI and AvaI. These two pieces were ligated and cloned into pEGFP-N1 (BD Biosciences Clontech, Palo Alto, CA) using the Rapid DNA ligation kit (Roche Diagnostics, Indianapolis, IN).
Transfection. HEK-293 cells were transiently transfected using the LipofectAMINE Plus transfection reagent (Invitrogen, Carlsbad, CA) with 5 g of DNA for approximately 2 ϫ 10 6 cells. The next day, they were replated for assay.
Intracellular Calcium Flux Measurements. Cells were plated 24 h before the experiment in poly-D-lysine-coated 96-well plates at a density of approximately 60,000 cells/well. In preparation of the assay, the confluent monolayer of cells was washed twice with Hanks' balanced salt solution supplemented with 20 mM Hepes and 2.5 mM probenecid (FLIPR buffer), and then the cells were loaded by adding 4 M Fluo-4 AM (Molecular Probes, Eugene, OR) in FLIPR buffer for 1 h at 37°C. After loading, the cells were then rinsed twice with FLIPR buffer, and intracellular calcium increases were detected by measuring increases in fluorescence with FLIPR after ligand addition. For ligand preincubation experiments, ligands were included during the dye loading step and 10 M 5-HT was added to detect the level of desensitized responses. In the experiments examining the effect of agonist preincubation, cells were washed before stimulation with 5-HT to evaluate desensitization without the confounding competition for agonist binding sites.
Internalization Measurements. Cells were plated 24 h before ligand addition in a 96-well plate at a density of approximately 25,000 cells/well. The next day, the cells were rinsed with OptiMem I (Invitrogen) and treated with up to 10 M of ligand in OptiMem I overnight at 37°C. The cells were then rinsed once with Hanks' balanced salt solution and fixed with 3% paraformaldehyde for 15 min. After rinsing the cells with Tris-buffered saline with 0.1% Triton X-100 the cells were then incubated for 15 min with 10 g/ml Hoechst 33342 in Tris-buffered saline with 0.1% Triton X-100. The cells were then rinsed with Tris-buffered saline and stored at 4°C. Images were then acquired at 20ϫ with the Arrayscan II (Cellomics) and analyzed using an imaging processing algorithm (Receptor Internalization) designed to identify ERCs per field of cells.
Confocal Microscopy. Cells were plated at approximately 50,000 cells/well on eight-well culture slides coated with poly-Dlysine (BD Biosciences, Bedford, MA) and treated as described above. After fixation, coverslips were mounted with the use of the ProLong Antifade kit (Molecular Probes). Images were acquired at 63ϫ with a TCS SP confocal system (Leica Microsystems, Inc., Deerfield, IL).
Results

Ligand Effects on Calcium Flux in HEK-293 Cells
Expressing 5-HT 2C -GFP. To ensure appropriate pharmacology of the tagged 5-HT 2C -GFP construct, functional validation was performed by measuring intracellular calcium flux using the FLIPR. Compounds previously described to function as agonists (5-HT, Ro 60-0175, WAY-161503, mCPP, and DOI), inverse agonists (SB-242084 and 5-methoxygramine), and antagonists (SB-206553 and mianserin) on the 5-HT 2C receptor were selected for measuring their effects on calcium flux. We monitored the time course of calcium flux in response to 10 M compound (Fig. 1A) and observed that the highest fluorescence counts (directly equated to the magnitude of calcium flux) were obtained with the agonists 5-HT and Ro 60-0175, whereas mCPP and DOI, compounds described previously as partial agonists for the 5-HT 2C receptor, had smaller maximal levels of calcium flux (Table 1) . The EC 50 values obtained for the agonists studied, estimated from the log concentration-response curves shown (Fig. 1B) showed that 5-HT was the most potent at 1.8 Ϯ 0.7 nM, with the least potent being mCPP at 49 Ϯ 18 nM (Table 1) . With the exception of Ro 60-0175 we observed a good correlation between the potencies of agonists to acutely stimulate Ca 2ϩ -signaling with their potencies to induce desensitization. All of the antagonists and inverse agonists tested showed no detectable calcium flux ( Fig. 1B; Table 1 ). In control experiments, none of the compounds used in this study stimulated a calcium response in nontransfected HEK cells (data not shown).
Desensitization and Antagonism Effects on Calcium Flux in HEK-293 Cells Expressing 5HT 2C -GFP. Pharmacological characterization was also evaluated for measuring agonist effects on desensitization as well as inverse agonist and antagonist effects on 5-HT-stimulated responses. After 30-min preincubation with agonists, inverse agonists, or antagonists, cells were subsequently challenged with 10 nM 5-HT. All of the agonists induced desensitization with EC 50 values in the range of 1.6 Ϯ 0.3 nM for 5-HT, the most potent, to 22 Ϯ 6 nM for mCPP, the least potent ( Fig. 2 ; Table 2 ). The inverse agonists and neutral antagonists exhibited antagonism under the same paradigm (Fig. 3) . The ranges of IC 50 values were from 3150 Ϯ 750 nM for 5-methoxygramine to less than 0.00015 Ϯ 0.00005 nM for SB-242084 (Table 3) .
Detection of 5HT 2C -GFP Internalization upon Agonist and Antagonist Incubation. The pharmacology of receptor internalization was determined by monitoring the accumulation of green fluorescence within centralized intracellular locations, which are consistent with ERCs. To quantitate these events, we used the Arrayscan II (Cellomics) automated cell-based imaging and analysis system, using their receptor internalization algorithm. Figure 4 , A-C, demonstrate the acquired Arrayscan images for 5-HT incubation with the applied algorithm shown as red overlay in A and C. Although under basal conditions the 5-HT 2C -GFP signal was predominantly associated with the cell surface (Fig. 4A ) application of the algorithm results in the detection of a small number of intense bright spots (red overlay). This highlights an important limitation of any automated imaging procedure intended to measure cell surface removal (or incorporation), the inability to be able to define the plasma membrane and to eliminate this background signal. Nevertheless, we observed that incubation with the natural ligand, 5-HT, produced an increase in the number of intense bright spots within the field (Fig. 4A, B) , which are also detectable by the algorithm and highlighted by the red overlay (Fig. 4A , C, same image with overlay). Ligand-induced internalization was monitored for 30 min, 1, 2, 4 h, and overnight (data not shown). Internalized receptors began to be detectable starting after approximately 1 h of ligand incubation, with overnight incubation, yielding results best detected with the Arrayscan. All of the results included in this study are from overnight incubation.
Confocal microscopy was also used to verify effects of 5-HT 2C receptor ligands on 5-HT 2C -GFP internalization. Only the agonists 5-HT, Ro 60-0175, and WAY-161503 were able to fully induce ERC formation (Fig. 4B, D-G) . The partial agonists mCPP and DOI induced formation of ERCs, albeit with significant remaining cell surface labeling (Fig.  4B, H and I) . The inverse agonists and antagonists did not induce internalization (Fig. 4B, J-M) .
Log concentration-response curves for the formation of ERCs, quantified automatically using the Arrayscan, after overnight incubation with the various ligands are shown (Fig. 5) . The agonists tested yielded EC 50 values that were greater than those obtained with FLIPR, ranging from 1.3-fold (Ro 60-0175) to 45-fold (5-HT) (compare Table 1 and Table 4 ). The antagonists and inverse agonists tested resulted in no internalization at any of the concentrations of ligand tested (Fig. 5B ).
Discussion
Although agonist-induced internalization is a well described phenomenon for many GPCRs, internalization by antagonists or inverse agonists has been documented for a limited number of GPCRs, suggesting this may be a receptorspecific property. In this study, we focused on determining the effects of a range of 5-HT 2C receptor ligands, including agonists, inverse agonists, and antagonists on receptor internalization. Our goal was to construct a 5HT 2C receptor-GFP fusion protein, validate pharmacological function, and then to monitor and quantitate any ligand-induced internalization using the Arrayscan II high content screening system (Cellomics) with their receptor internalization algorithm. This approach has been previously used for another member of the GPCR class of receptors, the parathyroid hormone receptor (Conway et al., 1999) .
All of the 5HT 2C receptor ligands tested with our 5HT 2C receptor-GFP fusion protein resulted in functional pharmacology for calcium flux within anticipated ranges, validating (Porter et al., 1999) . The values obtained in this study were between 2 and 50 nM, with the same rank order potency as the published values: 5-HT Ͼ DOI Ͼ Ro 60-0175 Ͼ mCPP. Similarly, WAY-161503, another compound shown to be a 5HT 2C receptor agonist (Cryan and Lucki, 2000) , also falls within this range at approximately 47 nM. The inverse agonists and antagonists were also within ranges anticipated from previous studies. SB-206553, mianserin, and SB-242084 have been shown to have the following IC 50 values, respectively: 12, 8.6, and 0.5 nM (Kennett et al., 1996 (Kennett et al., , 1997 Rauser et al., 2001) . Although those values were from a different functional assay, phosphoinositide hydrolysis, the values were similar to the IC 50 values we obtained with Ca 2ϩ mobilization studies performed using the FLIPR (Table 3 ). The only surprising difference is that we observed a more potent effect with SB-242084, 0.00015 nM compared with the published value of 0.5 nM for phosphoinositide hydrolysis (Kennett et al., 1997) . Although it is unclear as to why this discrepancy exists, it is clear that SB-242084 functioned as an extremely potent antagonist (n ϭ 4), and we have also confirmed this potent antagonism, with IC 50 in the subnanomolar range using a stable Chinese hamster ovary cell line expressing the human 5-HT 2C receptor (our unpublished observations). 5-Methoxygramine was the least potent antagonist tested, with an IC 50 of approximately 3 M. Such potency was also anticipated because the binding constant for 5-methoxygramine has been shown to be 1.45 M (Stollak and Furchgott, 1983 ).
Short-term pretreatment with all of the agonists resulted in functional desensitization of the 5-HT 2C -GFP receptor construct, as determined by measurement of 5-HT stimulated Ca 2ϩ mobilization after the agonist pretreatment(s). All of the agonists tested resulted in EC 50 values for desensitization of between 1.8 and 22 nM supporting the idea that upon activation, the receptor becomes desensitized. All agonists resulted in full desensitization at the maximal concentrations tested. Although this experiment demonstrates a decrease in receptor function, it does not address the means by which the receptor function decreases. Receptor localization studies were next performed to explore the possibility that receptors were being internalized, a mechanism contributing to desensitization. We used the Arrayscan II technology (Cellomics) to monitor the pharmacology of internalization of 5-HT 2C -GFP. Agonist incubation resulted in internalization of 5-HT 2C -GFP from the membrane to a single intracellular compartment. Each of the agonists tested was able to increase the basal level of ERCs detected by approximately 4-fold. It is also noteworthy that measuring internalization seems to be less sensitive than the calcium flux method for determining EC 50 values. The potential for the C-terminal GFP tag to interfere with appropriate receptor translocation is an important confounding variable likely to have a larger impact on internalization compared with functional coupling measured by calcium flux. In contrast, agonist intrinsic activities determined using the internalization assay were consistent with those determined in the Ca 2ϩ assay, as evidenced by the ability to distinguish full and partial agonists. Although all of the agonists were able to induce detectable levels of internalization, the amount of time required for internalization was greater for 5-HT 2C -GFP than other GPCRs, such as parathyroid hormone receptor and the ␣-adrenergic receptor, which have been demonstrated to show full internalization in under 1 h (Awaji et al., 1998; Conway et al., 2001) . To get consistent images with internalization of 5-HT 2C -GFP, it was necessary for us to permit the incubation with agonists to proceed overnight. We hypothesize that the reason for the longer internalization time is that the GFP tag on the c-terminal tail of the receptor could be inhibiting proper trafficking of the receptor. This hypothesis is supported by evidence that other neuronal GPCRs, such as metabotropic glutamate receptors, use their cytoplasmic carboxy-terminal domains for appropriate targeting in neurons (Stowell and Craig, 1999) . Also, a study has been performed comparing ligand regulation of GFP-tagged forms of ␤-adrenoceptors with unmodified receptors (McLean and Milligan, 2000) . This study specifically notes that c-terminal addition of GFP markedly decreased the rate of internalization of ␤-adrenoceptors in response to agonist and that sustained exposure to agonist (24 h) was able to completely internalize receptor from the cell surface.
In addition to the slower time course of internalization, it was also noteworthy that incubation with inverse agonists and neutral antagonists do not result in any detectable internalization of 5-HT 2C -GFP. This is specifically interesting because the 5-HT 2A receptor has been shown to be internalized by both agonists and antagonists (Willins et al., 1998) . The 5-HT 2C subtype of serotonin receptor seems to be different from 5-HT 2A in that antagonists do not induce internalization, at least when examined at the level of detecting internalized ERCs of a defined shape and size. This may prove to be a significant observation in helping to understand the differences in regulation of these two subtypes of serotonin receptor. During the course of submission of our study, Marion et al. (2004) reported differences in 5-HT 2C receptor internalization as a function of the edited isoform under evaluation. In the case of the VSV isoform tagged with GFP, they observed internalization after 5-HT treatment but not with SB-206553, an identical observation to ours. However, they also had sufficient resolution to detect a small proportion of constitutively internalized 5-HT 2C -VSV-GFP receptor, beyond the resolution of our analysis, which was externalized after treatment with SB206553. Furthermore, they demonstrated that the highly constitutively active INI isoform was predominantly intracellular, or constitutively internalized. These observations suggest that agonist-dependent internalization for the 5-HT 2C receptor will be critically dependent upon receptor isoform and be a more important property for investigation with fully and partially edited receptors such as VGV and VSV.
